Eric Chen

Eric Chen (born August 28, 1998) is a Chinese-American entrepreneur and blockchain developer. He is the co-founder and chief executive officer of Injective Labs.

Biography Chen was born in Shenzhen, China. He later moved to the United States, where he attended New York University (NYU), studying finance and computer science. During his time at NYU, Chen became involved in blockchain technology, contributing to open-source projects and participating in blockchain-related academic initiatives. From 2017 to 2018, Chen worked as a researcher at Innovating Capital, where his work included blockchain protocol research and trading strategies.

In 2018, Chen co-founded Injective Labs with Albert Chon. The company developed Injective Protocol, a blockchain platform designed for decentralized finance applications, including trading and derivatives.

In March 2023, Chen announced the release of the inSVM rollup, the first Solana Sealvel Virtual Machine (SVM) rollup intended for the Solana developer community and Cosmos users. In May, Eric Chen helped integrate Pyth with the Injective mainnet.

Injective Protocol is built using the Cosmos SDK and supports various financial products such as spot and derivatives trading.

In 2024, Forbes included Chen and Albert Chon in its 30 Under 30 Finance list as cofounders of Injective Labs.

Chen has also spoken at a number of conferences, including ETHCC ETH Denver, Avalanche Summit, Binance Blockchain Week, Permissionless, Messari Mainnet,